MedTrace Logo

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

NCT06448793 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2025-12-04

No results posted yet for this study

Summary

The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG

Approved Non-small Cell Lung Cancer (NSCLC) therapies

As prescribed by treating physician

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-25
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06448793 on ClinicalTrials.gov